Inventor
GLICK GARY
US16 patents
⚠️ This page may combine multiple inventors who share the name “GLICK GARY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
8 patentsUS11724992B2Aug 15, 2023
Compounds and compositions for treating conditions associated with NLRP activity
NOVARTIS AG1 citations71
US11203579B2Dec 21, 2021
Compounds and compositions for treating conditions associated with NLRP activity
NOVARTIS AG2 citations71
US11760735B2Sep 19, 2023
Compounds and compositions for treating conditions associated with NLRP activity
NOVARTIS AG0 citations62
US11597706B2Mar 7, 2023
Compounds and compositions for treating conditions associated with NLRP activity
NOVARTIS AG0 citations62
US11339136B2May 24, 2022
Compounds and compositions for treating conditions associated with NLRP activity
NOVARTIS AG0 citations62
US12084424B2Sep 10, 2024
Compounds and compositions for treating conditions associated with NLRP activity
NOVARTIS AG0 citations61
US11370763B2Jun 28, 2022
Compounds and compositions for treating conditions associated with NLRP activity
NOVARTIS AG1 citations61
US11447460B2Sep 20, 2022
Compounds and compositions for treating conditions associated with NLRP activity
NOVARTIS AG0 citations52
INNATE TUMOR IMMUNITY INC
5 patentsUS10604542B2Mar 31, 2020
Cyclic dinucleotides for treating conditions associated with sting activity such as cancer
INNATE TUMOR IMMUNITY INC5 citations83
US10533005B2Jan 14, 2020
NLRP3 modulators
INNATE TUMOR IMMUNITY INC9 citations83
US10961270B2Mar 30, 2021
Compounds and compositions for treating conditions associated with sting activity
INNATE TUMOR IMMUNITY INC2 citations72
US11505571B2Nov 22, 2022
Compounds and compositions for treating conditions associated with sting activity
INNATE TUMOR IMMUNITY INC0 citations62
US10723756B2Jul 28, 2020
Cyclic dinucleotides for treating conditions associated with STING activity such as cancer
INNATE TUMOR IMMUNITY INC0 citations51